Back
Inozyme Pharma Stock Price Chart
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly
Sell
50
INZY
Inozyme Pharma
Last Price:
4.46
Seasonality Move:
7.98%
7 Day Trial
ALL ACCESS PASS
$
7
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INZY is experiencing buying pressure, which is a positive indicator for future bullish movement.
Inozyme Pharma Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.46 | Sell |
| 20-day SMA: | 5.33 | Sell |
| 50-day SMA: | 5.81 | Sell |
| 200-day SMA: | 4.73 | Sell |
| 8-day EMA: | 4.55 | Sell |
| 20-day EMA: | 5.06 | Sell |
| 50-day EMA: | 5.41 | Sell |
| 200-day EMA: | 4.93 | Sell |
Inozyme Pharma Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.48 | Sell |
| Relative Strength Index (14 RSI): | 33.33 | Sell |
| Chaikin Money Flow: | 255484 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.52 - 6.72) | Sell |
| Bollinger Bands (100): | (4.22 - 6.14) | Sell |
Inozyme Pharma Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Inozyme Pharma Stock
Is Inozyme Pharma Stock a Buy?
- Inozyme Pharma share price is 4.44 while INZY 8-day simple moving average is 4.46, which is a Sell signal.
- The stock price of INZY is 4.44 while Inozyme Pharma 20-day SMA is 5.33, which makes it a Sell.
- Inozyme Pharma 50-day simple moving average is 5.81 while INZY share price is 4.44, making it a Sell technically.
- INZY stock price is 4.44 and Inozyme Pharma 200-day simple moving average is 4.73, creating a Sell signal.
INZY Technical Analysis vs Fundamental Analysis
Sell
50
Inozyme Pharma (INZY)
is a Sell
Is Inozyme Pharma a Buy or a Sell?
-
Inozyme Pharma stock is rated a Sell
The current Inozyme Pharma [INZY] share price is $4.44. The Score for INZY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Inozyme Pharma Stock Info
Market Cap:
274.27M
Price in USD:
4.44
Share Volume:
510.97K
Inozyme Pharma 52-Week Range
52-Week High:
7.80
52-Week Low:
2.69
Sell
50
Inozyme Pharma (INZY)
is a Sell
Inozyme Pharma Share Price Forecast
-
What is the Inozyme Pharma stock price today?
The Inozyme Pharma stock price is 4.44 USD today. -
Will INZY stock go up or go down?
Inozyme Pharma> share price is forecast to RISE/FALL based on technical indicators -
Is Inozyme Pharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Inozyme Pharma is overvalued.
Is Inozyme Pharma Stock a Buy?
- Inozyme Pharma share price is 4.44 while INZY 8-day exponential moving average is 4.55, which is a Sell signal.
- The stock price of INZY is 4.44 while Inozyme Pharma 20-day EMA is 5.06, which makes it a Sell.
- Inozyme Pharma 50-day exponential moving average is 5.41 while INZY share price is 4.44, making it a Sell technically.
- INZY stock price is 4.44 and Inozyme Pharma 200-day simple moving average is 4.93, creating a Sell signal.
Fundamental Analysis of Inozyme Pharma
Is Inozyme Pharma a good investment?
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and an increase next year of $0.01 per share.
Technical Analysis of Inozyme Pharma
Should I short Inozyme Pharma stock?
- INZY Moving Average Covergence Divergence (MACD) indicator is -0.48, suggesting Inozyme Pharma is a Sell
- Inozyme Pharma Relative Strength Index (RSI) is 33.33, which suggest Inozyme Pharma is oversold
- The Bollinger Bands (25) for Inozyme Pharma is (4.52 - 6.72), which suggest Inozyme Pharma is a Sell
- The Bollinger Bands (100) for Inozyme Pharma is (4.22 - 6.14), which suggest Inozyme Pharma is a Sell
* Inozyme Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.